Clinical Trial

TTVR STRONG Under Coverage With Evidence Development (CED) Study

Study acronym: STRONG
Recruiting
View on ClinicalTrials.gov →
Summary
This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Replacement procedure using the EVOQUE system.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-13.
Trial Details
NCT Number NCT06833476
Lead Sponsor Edwards Lifesciences
Conditions Tricuspid Regurgitation
Enrollment 2,044 participants
Start Date 2025-03-19
Primary Completion 2027-12-30 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-28